The ESC Handbook on Cardiovascular Pharmacotherapy

Description:

This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy. The Handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease. The Handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice. Two large sections of the book provide a comprehensive A-Z formulary of cardiac and non-cardiac pharmacological agents with practical and accessible information on the most important pharmacological aspects of these agents and their use in clinical practice. The Handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help. The print edition comes with full access to the online version that will be updated at yearly intervals to keep it up to date.

Table of Contents:

Classes of recommendations and levels of evidence

1 Cardiovascular disease prevention

1.1 Hypertension

1.2 Dyslipidaemia

1.3 Metabolic syndrome and diabetes

1.4 Thrombosis

2 Ischaemic heart disease

2.1 Acute coronary syndrome: STEMI and NSTEMI

2.2 Chronic stable angina

2.3 Coronary artery spasm and microvascular angina

2.4 Takotsubo syndrome

3 Heart failure

3.1 Heart failure

3.2 Heart transplantation

4 Arrhythmias

4.1 Atrial fibrillation

4.2 Supraventricular (narrow complex) tachycardias

4.3 Ventricular arrhythmias

4.4 Bradyarrhythmias

4.5 Syncope

5 Structural heart disease

5.1 Valvular heart disease

5.2 Myocarditis and pericardial syndromes

5.3 Cardiomyopathy

5.4 Pulmonary hypertension

6 Management of cardiovascular disease in pregnancy and lactation and in the presence of comorbidities

6.1 Kidney disease

6.2 Pregnancy and lactation

6.3 Liver disease

7 Major drug interactions

7.1 Major drug interactions

8 Cardiovascular drugs—from A to Z

8.1 Cardiovascular drugs—from A to Z

9 Non-cardiac drugs affecting the heart—from A to Z

9.1 Non-cardiac drugs affecting the heart—from A to Z

Index